Upendra Bhatnagar

Dr. Bhatnagar is the Vice-President and Test Facility Management of VIMTA’s Preclinical division. He has over two decades of pharmaceutical industry experience in nonclinical drug discovery and development (small and large molecules) along with toxicological assessment of Botanicals, Food Additives, Medical Devices and Agrochemicals in both R&D and CRO settings. He had held scientific and leadership roles with leading global organizations like Vanthys Pharmaceutical Development (Eli Lilly – JBL), Nektar Therapeutics, Lupin and Orchid. Prior to joining VIMTA in 2016, Dr. Bhatnagar worked with Cadila Healthcare Ltd. where he supported the development of NCEs, biologicals and generic drugs as Senior General Manager - Toxicology. He has published and presented several papers in international journals and seminars. Dr. Bhatnagar holds a PhD in Life Sciences from Bhopal University and MBA (TQM) from National Institute of Management. He received postdoctoral training in investigative and regulatory toxicology and is a European Registered Toxicologist.